Skip to content
FDA Approved
linkedin-circle
Link to Linkedin
twitter-circle
Link to Twitter
Contact Us
The State of Lung Imaging
About Xenon MRI
About Polarean
News and Press Releases
Events
Ethics & Compliance
Xenon MRI Platform
Inquiries
Clinical Research
Investors
Company Update
Posted on
February 16, 2023
by
Brady Anna
Post navigation
FDA Grants New Chemical Entity designation for XENOVIEW™ (xenon Xe 129 hyperpolarized)
Polarean to be a featured company at 2023 ATS Respiratory Innovation Summit
The State of Lung Imaging
About Xenon MRI
About Polarean
News and Press Releases
Events
Ethics & Compliance
Xenon MRI Platform
Inquiries
Clinical Research
Investors
